-- gm-Allergan rebuffed in seeking offers to combat Valeant bid-report
-- By Scott DiSavino
-- Sun May 11, 2014 11:59AM EDT
-- None



May 11 (Reuters) - U.S. medical firm Allergan Inc <AGN.N> declined to comment on Sunday on a report that it has been seeking offers from rival companies to combat Valeant Pharmaceuticals International's <VRX.TO> $47 billion cash and share offer. [ID:nL3N0NU4CP]

A spokeswoman for Allergan told Reuters on Sunday the company had no comment to make on whether it was seeking offers from other companies, following a report by Bloomberg that Allergan has so far been rebuffed by rival companies it has tried to interest in making an offer.